Collagen - biomaterial for drug delivery

被引:886
作者
Friess, W [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91058 Erlangen, Germany
关键词
biomaterials; collagen; crosslinking; devices; growth factors; injectables; ophthalmology; sponges;
D O I
10.1016/S0939-6411(98)00017-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of collagen as a biomaterial is currently undergoing a renaissance in the tissue engineering field. The biotechnological applications focus on the aspects of cellular growth or delivery of proteins capable of stimulating cellular response. However, basic knowledge about collagen biochemistry and the processing technology in combination with understanding of the physico-chemical properties is necessary for an adequate application of collagen for carrier systems. The purpose of this review article is to summarize information available on collagen dosage forms for drug delivery as well as to impart an overview of the chemical structures and the galenical properties including detailed description of the processing steps - extraction, purification, chemical crosslinking and sterilization. The most successful and stimulating applications are shields in ophthalmology, injectable dispersions for local tumor treatment, sponges carrying antibiotics and minipellets loaded with protein drugs. However, the scientific information about manipulating release properties or mechanistic studies is not as abundant as for some synthetic polymers. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:113 / 136
页数:24
相关论文
共 328 条
  • [1] ALTANKOV G, 1991, Journal of Biomaterials Science Polymer Edition, V2, P81, DOI 10.1163/156856291X00089
  • [2] INHIBITION OF CALCIFICATION INVIVO BY ACYL AZIDE CROSS-LINKING OF A COLLAGEN-GLYCOSAMINOGLYCAN SPONGE
    ANSELME, K
    PETITE, H
    HERBAGE, D
    [J]. MATRIX, 1992, 12 (04): : 264 - 273
  • [3] TISSUE REACTION TO SUBCUTANEOUS IMPLANTATION OF A COLLAGEN SPONGE - A HISTOLOGICAL, ULTRASTRUCTURAL, AND IMMUNOLOGICAL STUDY
    ANSELME, K
    BACQUES, C
    CHARRIERE, G
    HARTMANN, DJ
    HERBAGE, D
    GARRONE, R
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1990, 24 (06): : 689 - 703
  • [4] USE OF COLLAGEN SHIELDS AS A SURGICAL ADJUNCT
    AQUAVELLA, JV
    RUFFINI, JJ
    LOCASCIO, JA
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1988, 14 (05) : 492 - 495
  • [5] EFFICACY OF TOBRAMYCIN-SOAKED COLLAGEN SHIELDS VS TOBRAMYCIN EYEDROP LOADING DOSE FOR SUSTAINED TREATMENT OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA-INDUCED KERATITIS IN RABBITS
    ASSIL, KK
    ZARNEGAR, SR
    FOURAKER, BD
    SCHANZLIN, DJ
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 113 (04) : 418 - 423
  • [6] Bajpai PK, 1985, BIOCOMPATIBILITY TIS, P5
  • [7] PC12 cell aggregation and neurite growth in gels of collagen, laminin and fibronectin
    Baldwin, SP
    Krewson, CE
    Saltzman, WM
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1996, 14 (03) : 351 - 364
  • [8] Barnes M. J, 1982, COLLAGEN HLTH DISEAS, P179
  • [9] BAZIN S, 1976, METHODOLOGY CONNECTI, P13
  • [10] COLLAGEN SHIELDS AND INTRAOCULAR DRUG DELIVERY - CONCENTRATION OF GENTAMICIN IN THE AQUEOUS AND VITREOUS OF A RABBIT EYE AFTER LENSECTOMY AND VITRECTOMY
    BAZIUK, N
    GREMILLION, CM
    PEYMAN, GA
    CHO, HK
    [J]. INTERNATIONAL OPHTHALMOLOGY, 1992, 16 (02) : 101 - 107